中文版
英文版
Home
About us
About us
Company history
Company culture
Equipment
Chemical synthesis
Biological Mabs
Fermtation
Technology
Chemical synthesis
Biological Mabs
Products
Ophthalmology Series APIs
Monoclonal Antibody APIs
More competitive intermedites
Cell culture medium
News
Feedback
Contact us
Product Categories
Ophthalmology Series APIs
Monoclonal Antibody APIs
More competitive intermedites
Cell culture medium
5-Bromoacetyl-2-hydroxybenzaldehyde
6-N-Benzylamino-1-(4’-phenylbutoxy)Hexane
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
Products
Product
CAS No.
Purity
Caplacizumab
915810-67-2
97%(API grade)
Elotuzumab
915296-00-3
97%(API grade)
Romosozumab
909395-70-6
97%(API grade)
Necitumumab
906805-06-9
97%(API grade)
Blinatumomab
853426-35-4
97%(API grade)
Ibalizumab
680188-33-4
97%(API grade)
Inotuzumab ozogamicin
635715-01-4
97%(API grade)
Raxibacumab
565451-13-0
97%(API grade)
Siltuximab
541502-14-1
97%(API grade)
1
2
3
4
5
Copyright © Wuhan Sunrise Technology Development Company Limited All rights reserved. 2012.Supported by
www.hxchem.net
中文版 
英文版
Ophthalmology Series APIs
